Dexametasona e COVID-19

Notas do episódio

Podcast realizado pelos alunos Rute, Carol, Davi e Guilherme. Referências: CHIBBER, P. et al. Advances in the possible treatment of COVID-19: A review. European Journal of Pharmacology, [s.l.], v. 883, p.1-68, 2020. JOHNSON, R.M.; VINETZ, J.M. Dexamethasone in the management of covid -19. BMJ (Clinical research ed.), [s.l.], v. 330, 2020. MOAZZAM, M. et al. Understanding COVID-19: From Origin to Potential Therapeutics. Int J Environ Res Public Health., [s.l.], v. 17, n. 6, p. 5904, 2020. THEOHARIDES, T.C.; CONTI, P. Dexamethasone for COVID-19? Not so fast. Journal of Biological Regulators and Homeostatic Agents, [s.l.], v. 34, n. 3, 2020. TOMAZINI, B.M. et al. Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial. JAMA, [s.l.], 2020. WIERSINGA, W.J. et al. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA, [s.l.], v. 347, n. 8, p. 782-793, 2020.